title: Hypopituitarism and hypothyroidism following atrioventricular block during nivolumab treatment.
authors.affiliation: Department of Dermatology, University of Occupational and Environmental Health, Kitakyushu, Japan.
authors.forename: Tomoko
authors.initials: T
authors.lastname: Oda
authors.affiliation: Department of Dermatology, University of Occupational and Environmental Health, Kitakyushu, Japan.
authors.forename: Yu
authors.initials: Y
authors.lastname: Sawada
authors.affiliation: Department of Dermatology, University of Occupational and Environmental Health, Kitakyushu, Japan.
authors.forename: Etsuko
authors.initials: E
authors.lastname: Okada
authors.affiliation: Department of Dermatology, University of Occupational and Environmental Health, Kitakyushu, Japan.
authors.forename: Takashi
authors.initials: T
authors.lastname: Yamaguchi
authors.affiliation: Department of Dermatology, University of Occupational and Environmental Health, Kitakyushu, Japan.
authors.forename: Shun
authors.initials: S
authors.lastname: Ohmori
authors.affiliation: Department of Dermatology, University of Occupational and Environmental Health, Kitakyushu, Japan.
authors.forename: Sanehito
authors.initials: S
authors.lastname: Haruyama
authors.affiliation: Department of Dermatology, University of Occupational and Environmental Health, Kitakyushu, Japan.
authors.forename: Manabu
authors.initials: M
authors.lastname: Yoshioka
authors.affiliation: Department of Dermatology, University of Occupational and Environmental Health, Kitakyushu, Japan.
authors.forename: Motonobu
authors.initials: M
authors.lastname: Nakamura
mesh_terms: D000369:Aged, 80 and over; D000074322:Antineoplastic Agents, Immunological / Q000009:adverse effects*; D054537:Atrioventricular Block / Q000139:chemically induced* / Q000150:complications; D006801:Humans; D007018:Hypopituitarism / Q000097:blood / Q000175:diagnosis / Q000209:etiology*; D007037:Hypothyroidism / Q000097:blood / Q000175:diagnosis / Q000209:etiology*; D008297:Male; D008545:Melanoma / Q000175:diagnosis / Q000188:drug therapy; D000077594:Nivolumab / Q000009:adverse effects*; D012878:Skin Neoplasms / Q000175:diagnosis / Q000188:drug therapy
chemical_list: D000074322:Antineoplastic Agents, Immunological; D000077594:Nivolumab